tripotassium;trisodium;2-hydroxypropane-1,2,3-tricarboxylate;hydrate
-
tripotassium;trisodium;2-hydroxypropane-1,2,3-tricarboxylate;hydrate
structure -
-
CAS No:
55049-48-4
-
Formula:
C12H12K3Na3O15
-
Chemical Name:
tripotassium;trisodium;2-hydroxypropane-1,2,3-tricarboxylate;hydrate
-
Synonyms:
Uralyt-U;CG-120;Sodium citrate, potassium citrate, citric acid;55049-48-4;UNII-X6T6YN87SU;X6T6YN87SU;potassium sodium hydrogen citrate;Citric acid, trisodium salt, compd. with potassium citrate and citric acid, (2:2:1);Sodium citrate, potassium citrate, citric acid (2:2:1);DTXSID60203595;FT-0698576;tripotassium;trisodium;2-hydroxypropane-1,2,3-tricarboxylate;hydrate
-
CAS No:
tripotassium;trisodium;2-hydroxypropane-1,2,3-tricarboxylate;hydrate Basic Attributes
582.48 g/mol
581.8780470 g/mol
DTXSID60203595
Computed Properties
Molecular Weight:582.48
Hydrogen Bond Donor Count:3
Hydrogen Bond Acceptor Count:15
Rotatable Bond Count:4
Exact Mass:581.8780470
Monoisotopic Mass:581.8780470
Topological Polar Surface Area:282
Heavy Atom Count:33
Complexity:211
Covalently-Bonded Unit Count:9
Compound Is Canonicalized:Yes
Drug Function and Efficacy
Oral administration of urolate increases urine pH and citrate excretion, and decreases urine calcium concentration. This urolate-induced change makes the salts in the urine more susceptible to crystallization. The resulting decrease in calcium concentration can reduce the saturation of urine calcium salts that can form stones. The increase in pH can increase the solubility of uric acid and cystine stones.
Request for Quotation